GlassScriptPhysician profile
Anshuman Bansal
NPI 1366685273
$5,710.86
in general payments reported to CMS, 2019-2025
29 companies · $473 in 2025
The $473 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,565 · 2020: $171 · 2021: $522 · 2022: $1,077 · 2023: $358 · 2024: $546 · 2025: $473.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,377.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,376.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,171.49 | 2021-2024 | Osteocool Rf Ablation System |
| Boston Scientific Corporation | $958.50 | 2019-2025 | Embold Fibered, Therasphere Y90 Glass Microspheres 7.0 Gbq (US Commercial), Therasphere Administration Set |
| Medtronic USA, INC. | $487.71 | 2019-2020 | |
| Stryker Corporation | $450.11 | 2022-2024 | Optablate, Spinejack, Omnicurve |
| Penumbra, INC. | $405.15 | 2019 | |
| Medtronic Vascular, INC. | $398.30 | 2019 | |
| Cook Medical LLC | $346.71 | 2019-2020 | |
| Biocompatibles, INC. | $291.15 | 2019 | |
| Inari Medical, INC. | $225.78 | 2022-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Ethicon US, LLC | $161.40 | 2020-2024 | Neuwave |
| Eisai INC. | $142.51 | 2019-2024 | |
| Dova Pharmaceuticals | $110.77 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $79.36 | 2019-2020 | |
| Siemens Medical Solutions USA, INC. | $64.81 | 2022-2025 | Embozene |
| Terumo Medical Corporation | $63.15 | 2022 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $59.88 | 2021-2023 | Alphavac |
| Depuy Synthes Sales INC. | $49.12 | 2019 | |
| Trisalus Life Sciences, INC. | $36.72 | 2023 | Trinav Infusion System |
| Microvention, INC. | $33.17 | 2023 | Web Aneurysm Embolization System |
| Daiichi Sankyo INC. | $26.97 | 2024 | Injectafer |
| Abbvie INC. | $24.72 | 2023 | Duopa |
| Covidien LP | $18.29 | 2019 | |
| Janssen Biotech, INC. | $17.16 | 2020 | |
| Bard Peripheral Vascular, INC. | $17.06 | 2020 | |
| Merck Sharp & Dohme LLC | $17.05 | 2019 | |
| Genzyme Corporation | $15.47 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $14.21 | 2019 | |
| Advanced Accelerator Applications | $12.66 | 2020 | |
| Merit Medical Systems INC | $11.48 | 2024 | Aspira |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anshuman Bansal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.